CIDRAP newsletters options
Unvaccinated people may exercise and gather in small groups of vaccinated friends outdoors without a mask.
In the first weeks of the pandemic more-transmissible variants such as D614G became dominant.
With 362,757 new cases and 3,285 new deaths, India is receiving oxygen, drugs, vaccine, and other key supplies.
CARB-X announced today that it is awarding up to $3 million to GenomeKey of Bristol, United Kingdom, to develop an innovative rapid diagnostic test for sepsis.
People who work irregular or permanent shifts were associated with double the risk of COVID-19, according to findings from a Thorax study published yesterday. The study looked at 27,056 irregular and 21,836 permanent shift workers between ages 40 to 69, as well as 235,135 non-shift workers, all identified in the UK Biobank.
Tomorrow President Biden is expected to say the CDC has changed its guidance on wearing masks outdoors.
One study showed 91% protection for 1 dose of the Pfizer vaccine.
A WHO official says India's nearly vertical trajectory is astonishing—and an underestimate.
A point-prevalence study (PPS) conducted in six Indonesian hospitals found a high rate of empirical use of broad spectrum antibiotics, researchers reported today in JAC-Antimicrobial Resistance.
Men under 50 recovering from asymptomatic COVID have double the likelihood of acute ischemic strokes (AIS) compared with men of the same age without COVID infection, according to a study last week in JAMA Network Open.
Federal officials worry that parts of the country where vaccine uptake is low could become future virus hot spots.
The head of the WHO said the group is deeply concerned about rising cases and deaths and has redeployed 2,600 staff to help in India.
COVID-19 during pregnancy is tied to dramatically higher rates of maternal death, increased risk of infection, and adverse health outcomes in newborns.
The committee, in a 10-to-4 vote, recommends that the US resume use of the COVID-19 vaccine.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The results of a phase 2b clinical trial indicate 77% efficacy over 12 months of follow-up for a vaccine that targets malaria caused by Plasmodium falciparum, according to a preprint study published this week in The Lancet.
Last week the nation's vaccination rate dropped slightly for the first time, partly due to the J&J vaccine pause.
Today the numbers soared even higher, with 332,358 new cases and 2,255 deaths.
A study assessing use of a medical mask under a cloth mask for COVID-19 has some scientists concerned.
The study from 10 Brazilian cities adds to mounting evidence that the two drugs shouldn't be used in the treatment of COVID-19.
